notefromdoctor wrote:
Hormone and Metabolic Modulators
The following are prohibited:
1. Aromatase inhibitors including, but not limited to:
aminoglutethimide
anastrozole
androsta-1,4,6-triene-3,17-dione (androstatrienedione)
4-androstene-3,6,17 trione (6-oxo)
exemestane
formestane
letrozole
testolactone.
2. Selective estrogen receptor modulators (SERMs) including, but not limited to:
raloxifene
tamoxifen
toremifene.
3. Other anti-estrogenic substances including, but not limited to:
clomiphene
cyclofenil
fulvestrant.
4. Agents modifying myostatin function(s) including, but not limited, to:
myostatin inhibitors.
5. Metabolic modulators:
Insulins
Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists (e.g. GW 1516), PPARδ-AMP-activated protein kinase (AMPK) axis agonists (e.g. AICAR)
Peptide Hormones, Growth Factors and Related Substances
The following substances and their releasing factors are prohibited:
Erythropoiesis-Stimulating Agents [e.g. erythropoietin (EPO), darbepoetin (dEPO), hypoxia-inducible factor (HIF) stabilizers, methoxy polyethylene glycol-epoetin beta (CERA), peginesatide (Hematide)]
Chorionic Gonadotrophin (CG) and Luteinizing Hormone (LH) in males
Corticotrophins
Growth Hormone (GH), Insulin-like Growth Factor-1 (IGF-1), Fibroblast Growth Factors (FGFs), Hepatocyte Growth Factor (HGF), Mechano Growth Factors (MGFs), Platelet-Derived Growth Factor (PDGF), Vascular-Endothelial Growth Factor (VEGF) as well as any other growth factor affecting muscle, tendon or ligament protein synthesis/degradation, vascularisation, energy utilization, regenerative capacity or fibre type switching
and other substances with similar chemical structure or similar biological effect(s).